Surface Plasmon Resonance Market Report 2026

Surface Plasmon Resonance Market Overview

• Surface Plasmon Resonance market size has reached to $1.33 billion in 2025 • Expected to grow to $2.3 billion in 2030 at a compound annual growth rate (CAGR) of 11.5% • Growth Driver: Rising Adoption Of Personalized Medicine Fuels Growth In The Surface Plasmon Resonance Market • Market Trend: Advancements In Surface Plasmon Resonance (SPR) Technology • North America was the largest region in 2025.

What Is Covered Under Surface Plasmon Resonance Market?

Surface plasmon resonance (SPR) is an optical technique that measures the interaction between molecules by detecting changes in the refractive index on a sensor surface. It is widely used for real-time, label-free analysis of biomolecular interactions, such as protein-protein, protein-DNA, and antibody-antigen interactions. The main product types of surface plasmon resonance are imaging systems, sensor systems, and reagents. An imaging system is a device used to visualize and analyze the interactions between biomolecules in real-time. The various technologies include prism-based surface plasmon resonance (SPR), grating-based surface plasmon resonance (SPR), and others. It is used for varying applications, including drug discovery, drug formulation, controlled drug release, drug cell interaction, material science, and biosensors by different end-users, such as academic and research institutes, the food and beverage industry, biopharmaceutical companies, contract research organizations (CROS), and others.

What Is The Surface Plasmon Resonance Market Growth Forecast?

The surface plasmon resonance market size is expected to see rapid growth in the next few years. It will grow to $2.3 billion in 2030 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to increasing investment in biologics and biosimilars development, rising demand for high-throughput screening tools, expansion of personalized medicine research, growing adoption of biosensors in diagnostics, increasing focus on real-time molecular analytics. Major trends in the forecast period include increasing adoption of high-sensitivity spr imaging systems, rising demand for label-free biomolecular analysis, growing integration of spr in drug discovery pipelines, expansion of portable and multi-channel spr sensors, enhanced focus on real-time interaction analysis.

Global Surface Plasmon Resonance Market Segmentation

1) By Product Type: Imaging System, Sensor System, Reagents 2) By Technology: Prism-Based Surface Plasmon Resonance (SPR), Grating-Based Surface Plasmon Resonance (SPR), Other Technologies 3) By Application: Drug Discovery, Drug Formulation, Controlled Drug Release, Drug Cell Interaction, Material Science, Biosensors 4) By End-User: Academic And Research Institutes, Food And Beverage Industry, Biopharmaceutical Companies, Contract Research Organizations (CROs), Other End-Users Subsegments: 1) By Imaging System: 2D Imaging Systems, 3D Imaging Systems, High-Resolution Imaging Systems 2) By Sensor System: Optical Sensor Systems, Portable Sensor Systems, Multi-channel Sensor Systems 3) By Reagents: Binding Reagents, Sample Preparation Reagents, Stabilizing Reagents

What Is The Driver Of The Surface Plasmon Resonance Market?

The increasing adoption of personalized medicine is expected to propel the growth of the surface plasmon resonance market going forward. Personalized medicine is a tailored approach to healthcare that uses an individual's genetic, environmental, and lifestyle factors to design customized treatment and prevention strategies. The increasing adoption of personalized medicine is driven by advancements in genomics, the rise of targeted therapies, and the demand for more precise and effective treatments. Surface plasmon resonance helps in personalized medicine by enabling the real-time analysis of biomolecular interactions, helping to identify specific biomarkers, and optimizing drug therapies tailored to individual patients. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and health care organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from 6 in 2022. The newly approved personalized treatments for 2023 also include seven cancer drugs and three for other diseases and conditions. Therefore, the increasing adoption of personalized medicine drives the growth of the surface plasmon resonance industry.

Key Players In The Global Surface Plasmon Resonance Market

Major companies operating in the surface plasmon resonance market are GE HealthCare Technologies Inc., Sartorius AG, Cytiva, Bio-Rad Laboratories Inc., Bruker Corporation, HORIBA Ltd., Quanterix Corporation, Jubilant Biosys Limited, Quantum Design Inc., Reichert Inc., NanoSPR Devices, Creative BioMart Inc., Biocompare, Carterra Inc., NICOYA AB, Biosensing Instrument Inc., Plexera LLC, Insplorion AB, BioNavis Ltd., Affinité Instruments, IBIS Technologies B.V.

Global Surface Plasmon Resonance Market Trends and Insights

Major companies operating in the surface plasmon resonance market are focusing on developing advanced biomolecular analysis technologies, such as high-throughput SPR biosensor platforms, to gain a competitive advantage. SPR uses an optical phenomenon at metal–dielectric interfaces to detect binding events in real time without labels. For instance, in February 2023, Carterra, a US-based biotechnology instrumentation company, launched its high-throughput SPR platform, the LSA^XT, offering augmented sensitivity, greatly increased sample throughput, and reduced sample consumption, enabling efficient screening of membrane proteins, small molecules, and kinetic interactions. Such high-throughput, sensitive SPR systems allow pharmaceutical and biotech firms to accelerate drug discovery and biologics characterization. However, this shift also increases pressure on instrument vendors to ensure reproducibility and manage larger data volumes.

What Are Latest Mergers And Acquisitions In The Surface Plasmon Resonance Market?

In October 2024, Bruker Corporation, a U.S.-based manufacturer of scientific instruments for molecular and materials research, acquired Dynamic Biosensors GmbH (DBS) for an undisclosed amount. With this acquisition, Bruker aims to strengthen its biophysical instrumentation portfolio by combining its existing high-throughput surface plasmon resonance (SPR) systems with DBS’s innovative biosensor technologies, thereby enhancing its capabilities in molecular interaction and kinetics analysis. dynamic biosensors, a Germany-based developer of advanced biosensor platforms (notably the helix biosensor series) that facilitate detailed studies of molecular and cell-level interactions, supporting drug discovery and basic/medical research.

Regional Outlook

North America was the largest region in the surface plasmon resonance market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Surface Plasmon Resonance Market?

The surface plasmon resonance market consists of revenues earned by entities by providing services such as biosensor development services, assay development services, contract research services, data analysis services, and instrument maintenance and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The surface plasmon resonance market also includes sales of benchtop and portable SPR systems, metallic sensor chips, functionalized sensor chips, buffers, and solutions. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Surface Plasmon Resonance Market Report 2026?

The surface plasmon resonance market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the surface plasmon resonance industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.